IGF-1 gene therapy (Cardium)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIGF-1 gene therapy (Cardium)
Drug Alias NameCorgentinmyocardial-derived insulin-like growth factor-1 (IGF-1) (Cardium)Ad5IGF-1Genecor (FGF-4)acute myocardial infarction gene therapy(Cardium) +[6] 
ClassificationBiologics
Mechanisms of ActionInsulin-like growth factor I stimulants
TargetsInsulin-like growth factor I
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCollateral Therapeutics, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCollateral Therapeutics, IncGene Biotherapeutics IncBayer Schering Pharma AG
Active IndicationsN/A
Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A